Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

887 Press Releases
DateTitleCompany
22 Jul 15 Merck Announces Fourth-Quarter 2015 Dividend Merck,
Published by
Business Wire
21 Jul 15 Merck Marks 30-Year Milestone in Commitment to Innovation and Care in HIV/AIDS Merck ,
Published by
PharmiWeb.com
16 Jul 15 Award-Winning Actress S. Epatha Merkerson, Merck and the American Diabetes Association Challenge African Americans with Type 2 Diabetes to Get to Their A1C Goal Merck ,
Published by
PharmiWeb.com
10 Jul 15 Johann Heinrich Merck Award 2015 Goes to Gabriele Goettle Merck ,
Published by
PharmiWeb.com
07 Jul 15 Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program Merck ,
Published by
PharmiWeb.com
06 Jul 15 SIMPONI® Receives European Commission Approval for Treatment of Non-radiographic Axial Spondyloarthritis Merck Sharp & Dohme (MSD)
01 Jul 15 Merck To Fully Acquire Israeli Quantum Materials Company Qlight Nanotech Merck ,
Published by
PharmiWeb.com
30 Jun 15 Merck Launches More Than a Mother Campaign Aiming to Reduce Social Suffering of Infertile Women in Africa Merck ,
Published by
PharmiWeb.com
30 Jun 15 Merck Serono Introduces New Eeva Test Version Aiming for Optimized Assisted Reproductive Outcomes Merck Serono ,
Published by
PharmiWeb.com
29 Jun 15 Merck Announces Phase 3 Study of Single-Dose EMEND® (fosaprepitant dimeglumine) for Injection Regimen Met Primary Endpoint in Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy Merck,
Published by
PharmiWeb.com
26 Jun 15 Merck to Hold Second-Quarter 2015 Sales and Earnings Conference Call on July 28 Merck,
Published by
PharmiWeb.com
26 Jun 15 Merck to Hold Second-Quarter 2015 Sales and Earnings Conference Call on July 28 Merck,
Published by
Business Wire
17 Jun 15 Merck Manual and MSD Manual Launch Global Medical Knowledge 2020 to Provide Free Access to Credible Medical Information on Every Continent by 2020 Merck ,
Published by
PharmiWeb.com
15 Jun 15 Merck Millipore Expands Provantage® Biodevelopment Services with Addition of Provantage® Clone Generation Service Merck ,
Published by
PharmiWeb.com
15 Jun 15 Merck Millipore Introduces the Mobius® 2000 Liter Single-Use Bioreactor with Industry-leading Design for Ease-of-Use Merck ,
Published by
PharmiWeb.com
11 Jun 15 Merck Launches New Program That Encourages Women to “Rule the Real Talk” and Prioritize Their Sexual Health Merck,
Published by
PharmiWeb.com
11 Jun 15 Merck Serono Wins Two Red Dot Design Awards 2015 for High Quality Design of Fertility Pens Merck,
Published by
PharmiWeb.com
10 Jun 15 Merck and Samsung Bioepis Announce Pivotal Phase 3 Studies for Investigational Biosimilars SB4, Enbrel (Etanercept), and SB2, Remicade (Infliximab), Met Primary Endpoints Merck,
Published by
PharmiWeb.com
01 Jun 15 Merck and Dynavax Announce New Collaboration Investigating the Combination of Immuno-Oncology Therapies Merck,
Published by
Business Wire
01 Jun 15 FDA Accepts Supplemental Biologics License Application (sBLA) for KEYTRUDA® (pembrolizumab) Merck’s Anti-PD-1 Therapy in Advanced Non-Small Cell Lung Cancer and Grants Priority Review Merck,
Published by
Business Wire
03 Jun 15 CORRECTING and REPLACING CAPTION Merck KGaA Darmstadt Germany Celebrates 125 Years in the U.S. with Launch of “Smarter Together” Initiative Merck KGaA,
Published by
Business Wire
29 May 15 New Findings Show Durable Anti-Tumor Activity with KEYTRUDA® (pembrolizumab) Merck’s Anti-PD-1 Therapy in Patients with Advanced Head and Neck Cancer Regardless of PD-L1 Expression Status Merck,
Published by
Business Wire
08 Jun 15 Merck, Illumina and Genea Form the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment Merck,
Published by
PharmiWeb.com
08 Jun 15 TECOS Merck’s Cardiovascular Safety Trial of JANUVIA (sitagliptin) Met Primary Endpoint in Patients with Type 2 Diabetes Merck,
Published by
Business Wire
09 Jun 15 Consumerization Drives Growth at Merck Consumer Health Merck,
Published by
Business Wire
09 Jun 15 TECOS, Merck’s Cardiovascular Safety Trial of JANUVIA (sitagliptin), Met Primary Endpoint in Patients with Type 2 Diabetes Merck ,
Published by
PharmiWeb.com
10 Jun 15 New Data on Quality-of-Life Benefits of SIMPONI® (Golimumab) in Treating Patients with Active Non-Radiographic Axial Spondyloarthritis (nr-axial SpA) Merck Sharp and Dohme
10 Jun 15 Merck and Samsung Bioepis Announce Pivotal Phase 3 Studies for Investigational Biosimilars SB4 Enbrel (Etanercept) and SB2 Remicade (Infliximab) Met Primary Endpoints Merck,
Published by
Business Wire
03 Jun 15 Merck KGaA Darmstadt Germany Celebrates 125 Years in the U.S. with Launch of “Smarter Together” Initiative Merck KGaA,
Published by
Business Wire
08 Jun 15 Merck's KEYTRUDA™ (pembrolizumab) receives conditional approval in Canada for the treatment of advanced melanoma Merck Canada Inc.,
Published by
PR Newswire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.